Terms: = Leukemia AND ENO2, HEL-S-279, NSE AND Prognosis
4 results:
1. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract] [Full Text] [Related]
2. Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis.
Liu CC; Wang H; Wang JH; Wang L; Geng QR; Chen XQ; Lu Y
Oncotarget; 2016 Aug; 7(34):55181-55190. PubMed ID: 27409171
[TBL] [Abstract] [Full Text] [Related]
3. The use of cytochemical procedures in the diagnosis and management of acute and chronic myeloid leukemia.
Elghetany MT; MacCallum JM; Davey FR
Clin Lab Med; 1990 Dec; 10(4):707-20. PubMed ID: 1703064
[TBL] [Abstract] [Full Text] [Related]
4. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract] [Full Text] [Related]
